[Skip to Navigation]
August 1985

Response to Dr Alper's Editorial

Author Affiliations

Department of Dermatology New York University School of Medicine Skin and Cancer Unit 562 First Ave New York, NY 10016

Arch Dermatol. 1985;121(8):967. doi:10.1001/archderm.1985.01660080021002

To the Editor.—  Dr Alper1 has previously answered in a most learned way his own queries about the wholesale removal of all congenital nevocytic nevi (CNCN) by writing as follows, "There is no documented evidence from either retrospective or prospective studies that the small nevocellular nevus is a premalignant lesion. The question as to whether each of the small nevi should be removed will remain unanswered until these prospective studies have been carried out. The parents should be informed of the current debate concerning the premalignant potential of these lesions and of the options in management. If elective removal is carried out, it should be done as early as possible: the ensuing scar will be relatively smaller when the infant is larger. If elective removal is not carried out, we recommend that smaller nevocellular nevi (congenital moles) be observed for changes in color, granular pattern, size, itching, pain, and

Add or change institution